WallStreetZenWallStreetZen

NASDAQ: SILK
Silk Road Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for SILK

Based on 5 analysts offering 12 month price targets for Silk Road Medical Inc.
Min Forecast
$20.00-6.5%
Avg Forecast
$21.60+0.98%
Max Forecast
$24.00+12.2%

Should I buy or sell SILK stock?

Based on 5 analysts offering ratings for Silk Road Medical Inc.
Buy
Strong Buy
3 analysts 60%
Buy
0 analysts 0%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SILK stock forecasts and price targets.

SILK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-03-07
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2024-01-03

1 of 1

Forecast return on equity

Is SILK forecast to generate an efficient return?
Company
N/A
Industry
27.42%
Market
82.5%

Forecast return on assets

Is SILK forecast to generate an efficient return on assets?
Company
N/A
Industry
14.15%

SILK earnings per share forecast

What is SILK's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$1.43
Avg 2 year Forecast
-$1.34
Avg 3 year Forecast
-$1.24

SILK revenue forecast

What is SILK's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$198.0M+6.75%
Avg 2 year Forecast
$221.1M+19.18%
Avg 3 year Forecast
$240.9M+29.9%
SILK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SILK revenue growth forecast

How is SILK forecast to perform vs Medical Devices companies and vs the US market?
Company
9.23%
Industry
8.09%
Market
9.94%
SILK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SILK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SILK vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SILK$21.39$21.60+0.98%Buy
AVNS$19.24N/AN/A
CTKB$5.62$9.25+64.59%Strong Buy
AORT$23.12$27.50+18.94%Strong Buy
KIDS$29.30$39.00+33.11%Buy

Silk Road Medical Stock Forecast FAQ

Is Silk Road Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: SILK) stock is to Buy SILK stock.

Out of 5 analysts, 3 (60%) are recommending SILK as a Strong Buy, 0 (0%) are recommending SILK as a Buy, 2 (40%) are recommending SILK as a Hold, 0 (0%) are recommending SILK as a Sell, and 0 (0%) are recommending SILK as a Strong Sell.

If you're new to stock investing, here's how to buy Silk Road Medical stock.

What is SILK's earnings growth forecast for 2024-2026?

(NASDAQ: SILK) Silk Road Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.82%.

Silk Road Medical's earnings in 2024 is -$53,668,000.On average, 6 Wall Street analysts forecast SILK's earnings for 2024 to be -$56,337,677, with the lowest SILK earnings forecast at -$59,954,679, and the highest SILK earnings forecast at -$53,643,660. On average, 6 Wall Street analysts forecast SILK's earnings for 2025 to be -$52,657,564, with the lowest SILK earnings forecast at -$57,588,047, and the highest SILK earnings forecast at -$48,121,519.

In 2026, SILK is forecast to generate -$48,780,232 in earnings, with the lowest earnings forecast at -$52,854,783 and the highest earnings forecast at -$42,204,939.

What is SILK's revenue growth forecast for 2024-2026?

(NASDAQ: SILK) Silk Road Medical's forecast annual revenue growth rate of 9.23% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.94%.

Silk Road Medical's revenue in 2024 is $185,487,000.On average, 5 Wall Street analysts forecast SILK's revenue for 2024 to be $7,810,398,634, with the lowest SILK revenue forecast at $7,750,720,062, and the highest SILK revenue forecast at $7,931,767,416. On average, 5 Wall Street analysts forecast SILK's revenue for 2025 to be $8,719,934,786, with the lowest SILK revenue forecast at $8,603,890,927, and the highest SILK revenue forecast at $8,891,436,725.

In 2026, SILK is forecast to generate $9,503,684,444 in revenue, with the lowest revenue forecast at $9,339,913,504 and the highest revenue forecast at $9,703,191,528.

What is SILK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SILK) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 14.15%.

What is SILK's Price Target?

According to 5 Wall Street analysts that have issued a 1 year SILK price target, the average SILK price target is $21.60, with the highest SILK stock price forecast at $24.00 and the lowest SILK stock price forecast at $20.00.

On average, Wall Street analysts predict that Silk Road Medical's share price could reach $21.60 by May 1, 2025. The average Silk Road Medical stock price prediction forecasts a potential upside of 0.98% from the current SILK share price of $21.39.

What is SILK's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: SILK) Silk Road Medical's current Earnings Per Share (EPS) is -$1.38. On average, analysts forecast that SILK's EPS will be -$1.43 for 2024, with the lowest EPS forecast at -$1.52, and the highest EPS forecast at -$1.36. On average, analysts forecast that SILK's EPS will be -$1.34 for 2025, with the lowest EPS forecast at -$1.46, and the highest EPS forecast at -$1.22. In 2026, SILK's EPS is forecast to hit -$1.24 (min: -$1.34, max: -$1.07).

What is SILK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SILK) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.